Anamarija M. Perry

Nivolumab+AVD in Advanced-Stage Classic Hodgkin’s Lymphoma

Alex F. Herrera, Michael LeBlanc, Sharon M. Castellino et al. · New England Journal of Medicine · 2024 · 200 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Indolent T-cell lymphoproliferative disease of the gastrointestinal tract

Anamarija M. Perry, Roger A. Warnke, Qinglong Hu et al. · Blood · 2013 · 192 citations

Medicine, Immunology, Pathology +14

Non-Hodgkin lymphoma in the developing world: review of 4539 cases from the International Non-Hodgkin Lymphoma Classification Project

Anamarija M. Perry, J Diébold, Bharat N. Nathwani et al. · Haematologica · 2016 · 188 citations · Full text

Medicine, Hematology, Oncology +12

<scp>MYC</scp> and <scp>BCL</scp>2 protein expression predicts survival in patients with diffuse large <scp>B</scp>‐cell lymphoma treated with rituximab

Anamarija M. Perry, Yuridia Lizeth Alvarado-Bernal, Javier A. Laurini et al. · British Journal of Haematology · 2014 · 165 citations

Medicine, Immunology, Oncology +17

Activation of the STAT3 Signaling Pathway Is Associated With Poor Survival in Diffuse Large B-Cell Lymphoma Treated With R-CHOP

Xin Huang, Bin Meng, Javeed Iqbal et al. · Journal of Clinical Oncology · 2013 · 123 citations · Full text

Medicine, Cancer Biology, Oncology +12